M&A Deal Summary

Enveric Biosciences Acquires MagicMed Industries

On May 24, 2021, Enveric Biosciences acquired life science company MagicMed Industries

Acquisition Highlights
  • This is Enveric Biosciences’ 1st transaction in the Life Science sector.
  • This is Enveric Biosciences’ 1st transaction in Canada.
  • This is Enveric Biosciences’ 1st transaction in Alberta.

M&A Deal Summary
Date 2021-05-24
Target MagicMed Industries
Sector Life Science
Buyer(s) Enveric Biosciences
Deal Type Add-on Acquisition

Target

MagicMed Industries

Calgary, Alberta, Canada
MagicMed Industries is a biotechnology company focused on creating a library of novel derivative psychedelic molecules such as psilocybin, N,N-dimethyltryptamine (DMT) and other molecular derivatives with applications across multiple indications. MagicMed Industries is based in Calgary, Alberta.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Enveric Biosciences

Naples, Florida, United States
Category Company
Sector Life Science
Employees7
Revenue 40M USD (2019)
DESCRIPTION

Enveric Biosciences is a patient-first biotechnology company developing rigorously tested, novel cannabinoid medicines to improve quality of life for cancer patients. Initial indications include radiodermatitis, a common and often severe side effect of radiation therapy, and chemotherapy-induced neuropathy. Enveric Biosciences is based in Naples, Florida.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Alberta) 1 of 1
Country (Canada) 1 of 1
Year (2021) 1 of 1
Mergr

Product

Company

Legal